Daniel Levine’s Post

View profile for Daniel Levine, graphic

Principal at Levine Media Group

Behavioral health is one area of medicine that has lagged in the move towards precision medicine, in part because of a lack of high-quality evidence to drive decision-making. Holmusk is working to change that by using AI and real-world data to transform mental health care. Eze Abosi, chief growth officer for Holmusk, sits down with Amar Drawid, Ph.D., to discuss the need for standardized ways to measure symptoms for behavioral health conditions. They talk about how Holmusk is unlocking much-needed evidence to guide the successful development of new therapies, how its platform technology works, and why he believes it is charting a path for bringing precision medicines to people with mental health conditions. https://lnkd.in/g8KNs_5g? v=5jiWilRbWlc&ab_channel=LifeSciencesDNAPodcasthttps://lnkd.in/gRYSvWJ9

To view or add a comment, sign in

Explore topics